Managing high-priced biologic agents: challenges and potential solutions.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 33645239.
- Also identified by DOI 10.18553/jmcp.2021.27.3.411 and PMC identifier 10390996.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
<b>DISCLOSURES:</b> No funding was received for the writing of this commentary. The authors report no conflicts of interest.
Medical subject headings
- Biosimilar Pharmaceuticals
- Colitis, Ulcerative
- Immunologic Factors